```html

Autoimmune Thyroid Disease

What is Autoimmune thyroid disease?

Autoimmune thyroid disease (AITD) is a group of disorders in which the immune system mistakenly attacks the thyroid gland—a small, butterfly‑shaped organ at the base of the neck that produces hormones essential for metabolism, growth, and development. The two most common forms are Hashimoto’s thyroiditis (the body’s immune response leads to an underactive thyroid, or hypothyroidism) and Graves’ disease (the immune response results in an overactive thyroid, or hyperthyroidism). Both conditions involve the production of auto‑antibodies that target thyroid proteins, such as thyroid peroxidase (TPO), thyroglobulin, and the thyroid‑stimulating hormone receptor (TSHR).

Because thyroid hormones influence virtually every organ system, AITD can cause a wide range of symptoms—from subtle fatigue to life‑threatening cardiac arrhythmias. Early recognition, accurate testing, and appropriate treatment are essential for preventing complications.

Common Causes

Autoimmune thyroid disease is not caused by a single factor. Rather, it results from a complex interplay of genetic, environmental, and hormonal influences. The following are the most frequently identified contributors:

• Genetic predisposition – Certain HLA genes (e.g., HLA‑DR3, HLA‑DR5) and polymorphisms in the CTLA‑4 and PTPN22 genes increase susceptibility.
• Gender and hormones – Women are 5–10 times more likely to develop AITD, suggesting a role for estrogen and other sex hormones.
• Infections – Chronic viral or bacterial infections (e.g., Helicobacter pylori, Epstein‑Barr virus) can trigger molecular mimicry.
• Stress – Physical or emotional stress may precipitate the onset or exacerbation of autoimmunity.
• Iodine excess – High dietary iodine or iodine‑containing supplements can provoke thyroid autoimmunity, especially in genetically susceptible individuals.
• Smoking – Strongly linked to Graves’ disease and ophthalmopathy.
• Medications – Certain drugs (e.g., amiodarone, interferon‑α, lithium) can induce or worsen thyroid autoimmunity.
• Radiation exposure – Therapeutic neck radiation or environmental radiation can increase risk.
• Other autoimmune diseases – Co‑occurrence with type 1 diabetes, celiac disease, rheumatoid arthritis, or vitiligo is common.
• Family history – Having a first‑degree relative with AITD raises personal risk by 2–3 times.

Associated Symptoms

Symptoms differ depending on whether the thyroid is under‑ or over‑active, but many patients experience overlapping signs because autoimmunity itself can cause inflammation and tissue damage.

Symptoms of Hashimoto’s (hypothyroidism)

• Fatigue, sluggishness, and muscle weakness
• Weight gain despite unchanged diet
• Cold intolerance
• Constipation
• Dry, coarse skin and hair loss
• Depression or mood swings
• Menstrual irregularities or infertility
• Enlarged, painless thyroid (goiter)
• Elevated cholesterol levels

Symptoms of Graves’ (hyperthyroidism)

• Rapid heartbeat (palpitations) or atrial fibrillation
• Unexplained weight loss
• Heat intolerance and excessive sweating
• Tremor in the hands
• Insomnia and nervousness
• Bulging eyes (Graves’ ophthalmopathy)
• Fine, brittle hair and thinning of the skin
• Increased frequency of bowel movements

Symptoms common to both forms

• Neck swelling or a feeling of tightness
• Generalized muscle aches
• Cognitive difficulties (“brain fog”)
• Elevated or abnormal cholesterol and triglyceride levels

When to See a Doctor

Because thyroid dysfunction can evolve slowly, many people dismiss early signs. Seek medical evaluation promptly if you notice any of the following:

• Unexplained weight change (gain or loss) of >5 % within a few months.
• Persistent fatigue that does not improve with rest.
• Rapid or irregular heartbeat, especially with dizziness or fainting.
• New onset of tremor, heat/cold intolerance, or night sweats.
• Visible swelling at the front of the neck.
• Changes in menstrual cycle, difficulty conceiving, or symptoms of menopause before age 45.
• Eye changes such as bulging, redness, or double vision.
• Any sudden, severe symptoms listed in the “Emergency Warning Signs” section.

Diagnosis

Diagnosing AITD involves a combination of clinical assessment, laboratory testing, and imaging when needed.

1. Medical History & Physical Exam

• Review of symptom timeline, family history of autoimmune disease, and medication use.
• Palpation of the thyroid to assess size, consistency, and tenderness.
• Inspection for eye changes, skin texture, and heart rate.

2. Blood Tests

• Thyroid‑stimulating hormone (TSH) – First‑line test; high in hypothyroidism, low in hyperthyroidism.
• Free T4 and Free T3 – Measure active thyroid hormones; helpful for confirming the functional status.
• Thyroid auto‑antibodies:
  • Anti‑thyroid peroxidase (anti‑TPO) – Positive in >90 % of Hashimoto’s.
  • Anti‑thyroglobulin (anti‑TG) – May be present in both conditions.
  • TSH‑receptor antibodies (TRAb) – Specific for Graves’ disease.
• Additional labs to screen for related issues: lipid profile, fasting glucose, CBC, and vitamin D level.

3. Imaging

• Ultrasound – Determines gland size, nodularity, and vascularity; useful when a goiter is present.
• Radioactive iodine uptake (RAIU) scan – Differentiates between hyperthyroid causes (Graves’ vs. toxic nodular goiter).
• CT/MRI – Reserved for cases with compressive symptoms or suspected malignancy.

4. Fine‑Needle Aspiration (FNA)

Only performed if a thyroid nodule raises suspicion for cancer (e.g., irregular borders, rapid growth). It is not needed for pure autoimmune disease.

Treatment Options

Therapy is tailored to the type of AITD, severity of hormone imbalance, and patient preferences. The goals are to restore normal hormone levels, relieve symptoms, and prevent complications.

1. Medical Management

Hashimoto’s (Hypothyroidism)

• Levothyroxine – Synthetic T4 taken once daily on an empty stomach; dose adjusted based on TSH targets (usually 0.5–4.0 mIU/L). Brand‑name and generic formulations are equivalent.
• Combination T4/T3 therapy – Considered for patients who remain symptomatic despite normal TSH; requires careful monitoring.
• Periodic re‑evaluation of dose, especially after pregnancy, weight change, or new medications.

Graves’ (Hyperthyroidism)

• Antithyroid drugs (ATDs) – Methimazole (first‑line) or propylthiouracil (PTU) for first trimester pregnancy. They inhibit hormone synthesis and are used for 12–18 months or until remission.
• Beta‑blockers – Propranolol or atenolol to control heart rate, tremor, and anxiety while waiting for ATDs to take effect.
• Radioactive iodine (RAI) therapy – Single oral dose that destroys overactive thyroid cells; most common definitive treatment in the U.S.
• Surgery (thyroidectomy) – Indicated for large goiters, compressive symptoms, or contraindication to RAI.
• Management of Graves’ ophthalmopathy with steroids, orbital radiation, or surgical decompression when vision is threatened.

2. Lifestyle & Home Remedies

• Maintain a balanced diet rich in fruits, vegetables, lean protein, and whole grains.
• For hypothyroidism, ensure adequate iodine (but avoid excess) and consider selenium supplementation (200 µg/day) if anti‑TPO antibodies are high (supported by modest evidence [1]).
• Regular aerobic exercise (150 min/week) improves metabolism, mood, and cardiovascular health.
• Stress‑reduction techniques—mindfulness, yoga, or CBT—can lessen disease flares.
• Avoid smoking, especially if you have Graves’ disease, to reduce eye complications.
• Monitor weight, blood pressure, and heart rate at home; keep a symptom diary to discuss with your clinician.

3. Monitoring

After initiating therapy, most patients require follow‑up labs every 6–8 weeks until TSH stabilizes, then every 6–12 months. Those on RAI or post‑surgical patients are checked more frequently during the first year to detect hypothyroidism, which often follows treatment.

Prevention Tips

While you cannot completely prevent an autoimmune condition, several strategies may lower the risk of developing AITD or lessen its severity:

• Maintain adequate iodine intake—around 150 µg/day for adults (no more than 300 µg/day). Use iodized salt rather than high‑dose supplements unless directed.
• Limit exposure to known triggers—avoid unnecessary radiation to the neck and discuss medication risks with your doctor.
• Stay smoke‑free—smoking increases the odds of Graves’ disease and ophthalmopathy.
• Manage other autoimmune conditions—optimal control of diabetes, celiac disease, or lupus may reduce cross‑reactivity.
• Adopt a healthy lifestyle—regular exercise, stress management, and a diet rich in antioxidant‑bearing foods (berries, leafy greens) support immune balance.
• Screen at‑risk relatives—first‑degree relatives of patients with AITD should consider periodic TSH and antibody testing, especially if they develop symptoms.

Emergency Warning Signs

If you experience any of the following, seek immediate medical attention (go to the nearest emergency department or call emergency services):

• Sudden, severe chest pain or pressure.
• Rapid heart rate (>120 bpm) accompanied by shortness of breath, light‑headedness, or fainting.
• New or worsening double vision, eye bulging, or painful eye movement (possible sight‑threatening Graves’ ophthalmopathy).
• Severe, unexplained weight loss (>10 % of body weight in < 3 months) with muscle wasting.
• High fever, severe neck swelling, or difficulty swallowing/breathing (possible thyroid storm or acute thyroiditis).
• Confusion, agitation, or seizures—signs of thyrotoxic crisis.

Prompt treatment of these emergencies can be lifesaving.

---

References:

1. Garcia‑Mendoza, A., et al. “Selenium Supplementation in Autoimmune Thyroiditis.” Journal of Clinical Endocrinology & Metabolism, 2020. PMID: 32093858.
2. Mayo Clinic. “Hashimoto’s disease.” https://www.mayoclinic.org. Accessed April 2026.
3. American Thyroid Association. “Guidelines for Diagnosis and Management of Thyroid Disease.” 2023.
4. Centers for Disease Control and Prevention. “Iodine Deficiency.” https://www.cdc.gov. Accessed 2026.
5. World Health Organization. “Thyroid disorders.” WHO Fact Sheet, 2022.
6. Cleveland Clinic. “Graves’ Disease Treatment.” https://my.clevelandclinic.org. Accessed 2026.

```